Lotus eye hospital and Institute Limited has announced the resignation of its Company Secretary and Compliance Officer, marking a significant change in the company's key managerial personnel. The healthcare services provider informed stock exchanges about this corporate development through an official communication dated February 09, 2026.

Key Personnel Change Details

Mr. M Achuth Menon has tendered his resignation from the position of Company Secretary and Compliance Officer due to personal reasons. The resignation follows proper corporate governance protocols and regulatory compliance requirements.

Regulatory Compliance

The company has fulfilled its disclosure obligations pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement), 2015. The announcement was made to both major stock exchanges where the company's shares are listed.

The disclosure includes references to SEBI Circular No HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated November 11, 2024, and last updated on January 30, 2026. The company has provided detailed documentation including the resignation letter for regulatory review.

Management Communication

In his resignation letter, M Achuth Menon expressed gratitude to the management, Board of Directors, and the entire organization for their support and cooperation during his tenure. The resignation letter was addressed to Sangeetha Sundaramoorthy, Managing Director of the company.

The official communication was signed by Sangeetha Sundaramoorthy, Managing Director (DIN: 01859252), ensuring proper authorization and corporate governance compliance. The company maintains its headquarters in Coimbatore with multiple locations across Tamil Nadu and Kerala, continuing its healthcare services operations.

Vramath Financial Services Private Limited has disclosed a significant acquisition in lotus eye hospital through open market transactions, as per regulatory filing dated February 05, 2025. The acquisition represents a substantial increase in the company's shareholding and triggers disclosure requirements under SEBI regulations.

Acquisition Details

The transaction involves the acquisition of 20,84,835 equity shares, representing 10.02% of the total share capital of Lotus Eye Hospital and Institute Limited. The acquisition was completed through open market purchases on February 02, 2025.

Shareholding Pattern Changes

The acquisition significantly altered Vramath Financial Services' shareholding position in the target company. Prior to this transaction, the acquirer along with persons acting in concert held a modest stake of 1.73%.

Persons Acting in Concert

The disclosure identifies several entities and individuals acting in concert with Vramath Financial Services Private Limited:

• Vramath Investment Consultancy Private Limited
• PL.M.Palaniappan
• PL. Jayalakshmi
• PL.M.Palaniappan HUF
• PL. Ram Meyyappan

The acquirer has confirmed that it does not belong to the promoter or promoter group of the target company.

Regulatory Compliance

The disclosure was filed under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which mandates disclosure when shareholding crosses specific thresholds. The target company's shares are listed on both BSE Limited and National Stock Exchange of India Limited.

The total equity share capital of Lotus Eye Hospital and Institute Limited remains unchanged at 2,07,96,330 shares before and after the acquisition. The filing was signed by Jayalakshmi Palaniappan, Director of Vramath Financial Services Private Limited (DIN: 03524597), from Coimbatore on February 05, 2025.